Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...

Abatacept is linked to lower mortality and fewer hospitalizations than rituximab in patients with rheumatoid ...

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according ...

Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, ...

A Right To Information (RTI) response from Mumbai’s three biggest civic-run hospitals shows that only 0.3% of respiratory ...

Inhalational exposures to smoking, asbestos, dust, metals, and organics significantly increase the odds of developing interstitial lung disease.

Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...

The impact that Bernie Williams’ father had on him was immeasurable. Without the sage advice and caring personality of ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

Despite him and his wife's doubts, Blood gave GoFundMe a shot, creating a TikTok video inside the Mayo Clinic. It starred him and their kids sharing facts about the clinic and its history of ...

Jacob Sands, MD, discusses anaging Dato-DXd toxicities like stomatitis, eye irritation, and interstitial lung disease, which ...

Anti-Ro52 seropositivity is linked to increased rates of ILD progression and a decrease in progression-free and transplant-free survival.